0001193125-26-395671 Sample Contracts
LEASE AGREEMENTLease Agreement • September 18th, 2026 • TRex Bio, Inc. • Biological products, (no disgnostic substances)
THIS LEASE AGREEMENT (this “Lease”) is made this 15th day of April, 2026 (the “Effective Date”), between ARE-SAN FRANCISCO NO. 46, LLC, a Delaware limited liability company (“Landlord”), and TREX BIO, INC., a Delaware corporation (“Tenant”).
RESEARCH COLLABORATION AND LICENSE AGREEMENT BY AND AMONG ELI LILLY AND COMPANY, TREX BIO, INC., AND TREX HOLDINGS INC.Research Collaboration and License Agreement • September 18th, 2026 • TRex Bio, Inc. • Biological products, (no disgnostic substances) • New York
This Research Collaboration and License Agreement (this “Agreement”) is entered into as of January 6, 2023 (the “Execution Date”) and is effective as of the Antitrust Clearance Date (the “Effective Date”) except for Article 9 hereof, which shall be effective as of the Execution Date, by and among, on the one hand, Eli Lilly and Company, an Indiana corporation (“Lilly”), and, on the other hand, TRex Bio Inc., a Delaware company (“TRex”), and solely for purposes of Section 14.9, TRex Holdings Inc., a Delaware company (“Parent”). Lilly and TRex are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
FIRST AMENDMENT TO RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • September 18th, 2026 • TRex Bio, Inc. • Biological products, (no disgnostic substances)
This First Amendment to the Research Collaboration and License Agreement (this “First Amendment”), dated as of [XX], 2026 (“First Amendment Effective Date”), is made by and between Eli Lilly and Company, an Indiana corporation (“Lilly”), and TRex Bio, Inc., a Delaware corporation (“TRex”). Lilly and TRex are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Stock Option Agreement TRex Bio, Inc. 2024 Equity Incentive PlanStock Option Agreement • September 18th, 2026 • TRex Bio, Inc. • Biological products, (no disgnostic substances) • California
This Stock Option Agreement (this “Agreement”) is made and entered into as of the date of grant (the “Date of Grant”) set forth on the Notice of Stock Option Grant attached as the facing page to this Agreement (the “Grant Notice”) by and between TRex Bio. Inc., a Delaware corporation (the “Company”), and the optionee named on the Grant Notice (“Optionee”). Capitalized terms not defined in this Agreement shall have the meaning ascribed to them in the Company’s 2024 Equity Incentive Plan (the “Plan”) or in the Grant Notice, as applicable.